Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 8,402

Document Document Title
WO2007028239B1
The isolation and identification of two O-methyltransferases from the hops plant (Humulus lupulus L.), designated as OMT1 (SEQ ID NO. 1) and OMT2 (SEQ ID NO. 3) is described.  
WO/2007/082178A3
A method of inhibiting 15-keto prostaglandin-Δ13-reductase 2 by contacting 15-keto prostaglandin-Δ13-reductase 2 with an aryl compound of Formula (I), (II), (III), or (IV) shown herein. Also disclosed are methods of treating peroxisome...  
WO/2007/078263A2
Technical solution is related to industry production microorganism Streptomyces toxytricini CCM 7349 and method of lipstatin biotechnology preparation by this strain. Production strain listed above with use of two step vegetative inoculu...  
WO/2007/078263A3
Technical solution is related to industry production microorganism Streptomyces toxytricini CCM 7349 and method of lipstatin biotechnology preparation by this strain. Production strain listed above with use of two step vegetative inoculu...  
WO/2007/074060A1
The invention relates to a method for production of optically active (1S)-3-chloro-1-(2-thienyl)-propan-1-ol of formula (I), wherein 3-chloro-1 -(2-thienyl)-propan-1-one of formula (II) is reduced in a medium to give the compound of form...  
WO2007035693A9
Novel isonitrile biosynthetic enzymes isnA and isnB which together possess a catalytic activity of converting an amine-containing compound to an isonitrile-containing compound are described. The genes that encode such enzymes, recombinan...  
WO/2007/074070A1
The invention relates to a method for producing optically active alkanols of formula (I), in which n represents a whole number from 0 to 5; Cyc represents an optionally substituted, mononuclear or polynuclear, saturated or unsaturated, c...  
WO/2007/071599A3
A process for the production of an optically enriched tertiary alcohol of the formula (2a) or (2b), by reacting an epoxide of the formula (1) with a nucleophilic agent Nu in the presence of halohydrin dehalogenase.  
WO/2007/068498A1
The invention relates to a process for the preparation of δ-lactones by reacting acetaldehyde and a substituted acetaldehyde in the presence of an aldolase, preferably a DERA from Escherichia coli, from Bacillus subtilis or from a Geoba...  
WO/2007/067698A2
The invention concerns a method having the steps of: combining an aqueous fermentation broth containing ansamitocins with a water-immiscible solvent and a water-soluble solvent to form an organic layer and an aqueous layer, wherein: (i) ...  
WO/2007/067698A3
The invention concerns a method having the steps of: combining an aqueous fermentation broth containing ansamitocins with a water-immiscible solvent and a water-soluble solvent to form an organic layer and an aqueous layer, wherein: (i) ...  
WO/2007/063866A1
An industrially advantageous process for producing a compound capable of inhibiting an HMG-CoA reductase and having an activity of decreasing the serum cholesterol level, which is characterized by using a protein comprising an amino acid...  
WO/2007/051651A1
Disclosed are strains of fungus Claviceps purpurea (Fr.) Tul., that produce a high content of total ergot peptide alkaloids and an amount of beta-ergokryptine greater than the amount of alpha-ergokryptine during parasitic growth on a cer...  
WO/2007/046943A2
The present invention relates to the production process of biotin by fermentation using genetically engineered microorganisms, including Escherichia coli and Pseudomonas mutabilis, and DNA sequences and vectors to be used in such process.  
WO2005104864A8
Edible oil comprising statin comprising at least 90% of di- and/or triglycerides having a saturated fatty acid (SAFA) content of less than 25 wt%, preferably containing at least 4 mg/g statin. Process for the preparation of an edible oil...  
WO2005104871A8
A composition comprising statin wherein the composition is a flour comprising less than 10 wt.% of fat and the use of the composition comprising statin in the preparation a food product is disclosed. The process for the preparation of th...  
WO/2007/040082A1
Disclosed is a composition for treatment of nephritis which contains a triprenyl phenol compound as an active ingredient. The composition preferably contains a triprenyl phenol compound represented by the general formula (I) below as an ...  
WO/2007/039816A3
The present invention relates to improved fermentation processes for the preparation of tacrolimus or a salt or derivative thereof by culturing a microorganism capable of producing tacrolimus or a salt or derivative thereof under submerg...  
WO/2007/039816A2
The present invention relates to improved fermentation processes for the preparation of tacrolimus or a salt or derivative thereof by culturing a microorganism capable of producing tacrolimus or a salt or derivative thereof under submerg...  
WO/2007/035693A3
Novel isonitrile biosynthetic enzymes isnA and isnB which together possess a catalytic activity of converting an amine-containing compound to an isonitrile-containing compound are described. The genes that encode such enzymes, recombinan...  
WO/2007/030772A3
Genetically engineered Streptomyces clavuligerus strains with improved capabilities to produce clavulanic acid are provided. The strains are genetically engineered by disrupting newly identified glyceraldehyde-3-phosphate dehydrogenase (...  
WO/2007/028602A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2007/028609A1
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2007/030662A1
Disclosed are methods of modulating biosynthesis of Salinosporamide A and its analogs, which are useful in treating cancer, inflammatory conditions, and/or infectious disease. The methods involve, for example, genetic manipulation, selec...  
WO/2007/028239A2
The isolation and identification of two O-methyltransferases from the hops plant (Humulus lupulus L.), designated as OMT1 (SEQ ID NO. 1) and OMT2 (SEQ ID NO. 3) is described.  
WO/2007/028239A3
The isolation and identification of two O-methyltransferases from the hops plant (Humulus lupulus L.), designated as OMT1 (SEQ ID NO. 1) and OMT2 (SEQ ID NO. 3) is described.  
WO2006136521A8
A process is described for the preparation of escitalopram and the pharmaceutically acceptable salts thereof starting from 5-cyanophthalide by a process which provides an enantioselective enzymatic deacylation reaction of a complex of th...  
WO2006134623B1
The present invention describes a method for increasing the survival of the bacteria of Rhizobium genus, comprising the steps of: making the bacteria to grow in a chemically defined medium; keeping the bacteria in growth stationary phase...  
WO/2007/018194A1
It is intended to provide a method for producing cercosporamide, characterized by culturing a bacterium belonging to the genus Lachnum and/or a bacterium belonging to the genus Pseudaegerita and collecting cercosporamide from the culture...  
WO/2007/015511A1
A novel D-amino acid oxidase isolated and purified from Candida intermedia; a gene encoding the D-amino acid oxidase; a recombinant plasmid carrying the gene; a transformant having the D-amino acid oxidase gene introduced therein; a meth...  
WO/2007/014971A3
The invention relates to genes involved in the biosynthesis of thiocoraline and to the heterologous production of same. According to the invention, the cluster of genes responsible for the biosynthesis of thiocoraline was identified and ...  
WO/2007/014971A2
The invention relates to genes involved in the biosynthesis of thiocoraline and to the heterologous production of same. According to the invention, the cluster of genes responsible for the biosynthesis of thiocoraline was identified and ...  
WO2005118777A8
The invention relates to a novel strain Saccharothrix actinomycete SA 103 deposited at CNCM on 16th February 2004, number I-3160 or a mutant strain thereof; a method and a medium for selection of said strain; and a method for the product...  
WO/2007/010944A1
The invention relates to a method for producing an optically active 2-(N-substituted aminomethyl)-3-hydroxybutyric acid ester, characterized by allowing an enzyme source having an activity of stereoselectively reducing a 2-(N-substituted...  
WO/2007/007986A1
Provided is S-adenosylmethionine-6-N-lysine-methyltransferase obtained from Neυrospora crassa, a polynucleotide encoding the same, a vector and host cell containing the polynucleotide, and a method of producing trimethyllysine by cultur...  
WO/2007/007399A1
Compounds having an anti-MRSA activity and having a skeleton and action mechanism different from those of existing drugs, which are useful as a novel antimicrobial agent. Conventionally, vancomycin is used as a drug for MRSA. However, re...  
WO/2007/003574A1
A method for making dihydroxyacetone phosphate (DHAP) comprising treating dihydroxyacetone with a bacterial acid phosphatase in the presence of pyrophosphate. The invention further pertains to a method for making, preferably in one pot, ...  
WO/2007/001406A3
The present invention discloses novel compounds, compositions containing the compounds and methods for the treatment of viral infection, particularly hepatitis C and SARS. In particular the invention provides aryl-containing macrocyclic ...  
WO/2006/136521A1
A process is described for the preparation of escitalopram and the pharmaceutically acceptable salts thereof starting from 5-cyanophthalide by a process which provides an enantioselective enzymatic deacylation reaction of a complex of th...  
WO/2006/134623A1
The present invention describes a method for increasing the survival of the bacteria of Rhizobium genus, comprising the steps of: making the bacteria to grow in a chemically defined medium; keeping the bacteria in growth stationary phase...  
WO/2006/134482A1
A novel process for producing atrovastatin, pharmaceutically acceptable salts thereof, and intermediates thereof using an aldolase is described. Compounds so prepared are useful as inhibitors of the HMG-CoA reductase and may thus be used...  
WO/2006/134374A2
There is provided a method for producing L-ascorbic acid (vitamin C) in which the enzymes tagatose epimerase and fucose isomerase are co-incubated with a micro-organism able to convert L-galactose to L- ascorbic acid. The micro-organism ...  
WO/2006/134374A3
There is provided a method for producing L-ascorbic acid (vitamin C) in which the enzymes tagatose epimerase and fucose isomerase are co-incubated with a micro-organism able to convert L-galactose to L- ascorbic acid. The micro-organism ...  
WO/2006/133332A3
A process for the enzyme-catalyzed preparation of cyclic ester oligomers from dicarboxylic acids and/or dicarboxylic acid derivatives and diols, hydroxycarboxylic acids and/or hydroxycarboxylic acid esters, and/or linear ester oligomers ...  
WO2006084706A3
The present invention relates to newly identified genes that encode proteins that are involved in the synthesis of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also features polynucleotides comprising the fu...  
WO/2006/133332A2
A process for the enzyme-catalyzed preparation of cyclic ester oligomers from dicarboxylic acids and/or dicarboxylic acid derivatives and diols, hydroxycarboxylic acids and/or hydroxycarboxylic acid esters, and/or linear ester oligomers ...  
WO/2006/131098A2
The invention relates to a method for producing rhizoxin and derivatives of rhizoxin. The aim of the invention is to produce novel micro-organisms that synthesise rhizoxin or derivatives of rhizoxin, and to provide a method for producing...  
WO2006084644A3
The present invention relates to newly identified microorganisms capable of direct production of L-ascorbic acid (hereinafter also referred to as Vitamin C). The invention also relates to polynucleotide sequences comprising genes that en...  
WO/2006/131098A3
The invention relates to a method for producing rhizoxin and derivatives of rhizoxin. The aim of the invention is to produce novel micro-organisms that synthesise rhizoxin or derivatives of rhizoxin, and to provide a method for producing...  
WO/2006/130657A2
The invention relates to a process for the enzymatic, stereoselective reduction of ketone compounds to provide chiral alcohols, for example the compound of formula (Ib).  

Matches 551 - 600 out of 8,402